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Importance 
Leishmaniasis is one of the most important vector-borne diseases of humans. 
This parasitic disease can be caused by many species of Leishmania, most of which 
are zoonotic. In humans, different species of the parasite are associated with different 
forms of the disease. Many Leishmania spp. cause skin ulcers and nodules. A few of 
these organisms can also affect the mucous membranes, and may cause disfiguring 
lesions of the nose. Other species damage the internal organs and cause human 
visceral leishmaniasis, a life-threatening condition. Among domesticated animals, 
dogs are the most important species in the epidemiology of this disease. In addition to 
becoming ill, dogs are reservoir hosts for L. infantum, one of the two most important 
organisms in human visceral leishmaniasis. Skin lesions and, rarely, visceral disease, 
have also been reported occasionally in other domesticated animals, captive mammals 
in zoos, and wild animals. 
Etiology 
Leishmaniasis results from infection by various species of Leishmania, a 
protozoan parasite of the family Trypanosomatidae (order Kinetoplastida). 
Approximately 30 species have been described, and at least 20 of these organisms are 
pathogenic for mammals. The genus Leishmania contains two subgenera, Leishmania 
and Viannia, which are differentiated by where they multiply in the digestive tract of 
the insect vector. The classification of Leishmania is complex and, in some cases, 
controversial; more than one species name may be used for an organism, and some 
names may eventually be invalidated. 
Human visceral leishmaniasis is primarily caused by Leishmania donovani 
(which includes L. archibaldi) and L. infantum/ L. chagasi. L. donovani is 
anthroponotic; it is mainly transmitted between people, who act as the reservoir hosts. 
L. infantum is zoonotic. At one time, two different names were used for this organism 
- L. infantum in the “Old World” (Eastern Hemisphere) and L. chagasi in the “New 
World” (Western Hemisphere) – and these two organisms were thought to be 
different species. As a result of genetic studies, they have been reclassified into one 
species, L. infantum. However, some authors argue that L. chagasi should be a 
subspecies of L. infantum, and the name L. chagasi is still used frequently in South 
America. Other organisms can occasionally cause visceral leishmaniasis: L. tropica 
and L. amazonensis, which usually cause cutaneous leishmaniasis, and a newly 
described species in Thailand, have been linked to some cases. 
Most Leishmania species cause cutaneous leishmaniasis in people. In the New 
World, these organisms include the members of the L. braziliensis complex (L. 
braziliensis, L. panamensis/ L. guyanensis, L. shawi and L. peruviana,) and the L. 
mexicana complex (L. mexicana, L. amazonensis, L. venezuelensis), as well as L. 
lainsoni, L. naiffi and L. lindenbergi. Old World species that cause cutaneous 
leishmaniasis include L. tropica, L. major and L. aethiopica, which are all members 
of the L. tropica complex. In addition, some strains of L. infantum can cause 
cutaneous leishmaniasis without affecting the internal organs. With the exception of 
the anthroponotic species L. tropica, all of these organisms are zoonotic. The type of 
skin lesions, efficacy of treatment, speed of healing and other factors vary with the 
species. Most Old World and New World species only cause lesions on the skin, but 
the New World organisms L. braziliensis and L. panamensis/L. guyanensis may cause 
either cutaneous or mucocutaneous leishmaniasis. 
L. infantum is the most common species reported in domesticated animals, but 
other species also occur. The distinction between species that cause cutaneous and 
visceral syndromes is not seen in animals. For example, L. infantum, which mainly 
causes visceral leishmaniasis in people, can cause both visceral and cutaneous disease 
in dogs, and primarily causes skin lesions in cats and horses. Some Leishmania 
species that have been isolated from animals have not been reported in humans: 
Geographic Distribution 
With the exception of Antarctica, Leishmania spp. have been reported on every 
continent. These organisms are primarily endemic in tropical and sub-tropical regions  
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and human disease mainly occurs in Africa, parts of Asia, 
the Middle East, Latin America and the Mediterranean 
region. In Europe, leishmaniasis appears to be spreading 
northward from its traditional foci.  
The distribution of each species of Leishmania affects 
the type of disease that occurs in each region, as well as its 
severity. L. donovani causes visceral leishmaniasis in South 
Asia and Africa. L infantum causes this disease in the 
Mediterranean, the Middle East, Latin America and parts of 
Asia. Cutaneous leishmaniasis is caused by L. major in 
Africa, the Middle East and parts of Asia, by L. tropica in 
the Middle East, the Mediterranean and parts of Asia, and 
by L. aethiopica in parts of Africa. Many different species 
may be involved in the Western Hemisphere, where 
cutaneous leishmaniasis can be found from Mexico through 
South America.  
In North America, limited foci of infection have been 
reported in Canada and the U.S. Canine leishmaniasis 
caused by L. infantum and occurring mainly in Foxhounds 
has been reported in a number of U.S. states and parts of 
Canada. Human cases have not been linked to these 
animals. In addition, a focus of cutaneous leishmaniasis that 
has sporadically affected humans or domesticated animals 
is found in south central Texas, where a species of 
Leishmania (possibly a member of the L. mexicana 
complex) seems to be endemic. Australia appeared to be 
free of Leishmania spp. until 2004, when this organism 
began to be reported from captive kangaroos, wallabies and 
other marsupials. Imported cases of leishmaniasis can also 
be seen in areas where Leishmania spp. are not endemic. If 
appropriate insect vectors are not present, these organisms 
usually do not become established in the country. 
Transmission 
Leishmania spp. are usually transmitted indirectly 
between hosts by sandflies of the genera Phlebotomus and 
Lutzomyia, which are biological vectors. Each species of 
Leishmania is adapted to transmission in certain species of 
sandflies. Only the females feed on blood. Sandfly activity 
occurs when it is humid, and there is no wind or rain. These 
insects are usually most active at dawn, dusk and during the 
night, but they will bite if they are disturbed in their hiding 
places (animal burrows, holes in trees, caves, houses and 
other relatively cool, humid locations) during the day. They 
are attracted to light and may enter buildings at night. 
Transovarial transmission of Leishmania does not seem to 
occur, and in areas with cold temperatures, the parasite 
overwinters in mammalian hosts. Other arthropods 
including ticks (Dermacentor variabilis and Rhipicephalus 
sanguineus) and canine fleas may also act as mechanical 
vectors. Where sandflies transmit Leishmania spp., ticks 
and fleas are probably unimportant in the epidemiology of 
the disease; however, they might be involved in rare cases 
of dog-to-dog transmission in other locations. 
Mammals can be infected asymptomatically for long 
periods, and they often remain chronically infected even 
after clinical cure. Subclinically infected animals can 
transmit Leishmania to sandflies. These parasites have also 
been transmitted via blood transfusions in people and dogs, 
and by transplacental transmission in dogs, mice and 
humans. In canine leishmaniasis caused by L. infantum, the 
parasites can sometimes be found in saliva, urine, semen 
and conjunctival secretions, as well as in blood. Venereal 
transmission has been proven to occur in dogs, and other 
routes of spread might be possible. Rare cases of horizontal 
transmission have been reported between dogs in the same 
household or kennel. Case histories suggest that some of 
these animals might have been infected during a fight. In 
other cases, a dog is known to have licked its companion’s 
lesions or ingested blood during a hemorrhage. 
Epidemiological investigations in U.S. Foxhounds also 
suggest that L. infantum has been transmitted directly from 
dog to dog, although sandfly mediated transmission or other 
arthropod-borne transfer has not been ruled out. In contrast, 
sandflies are thought to transmit the disease to people from 
wild mammals in south-central Texas. The risk of direct 
transmission from infected dogs to humans is unknown.  
Epidemiology 
Humans and domesticated animals are accidental hosts 
for many Leishmania spp., which are maintained in cycles 
between wild animals and sandflies. L. infantum, L. 
peruviana and possibly other species can be maintained in 
dogs, increasing the risk of transmission to people. Other 
domesticated animals might be involved as secondary 
maintenance hosts. L. donovani and L tropica are adapted 
to humans, but animals can also be infected occasionally. 
Disinfection 
Leishmania spp. do not remain viable outside a host or 
in vitro culture. They can be inactivated by 1% sodium 
hypochlorite, 2% glutaraldehyde, or formaldehyde. They 
are also susceptible to heat of 50–60°C. 
Infections in Humans 
Incubation Period 
People can carry some species of Leishmania 
asymptomatically for long periods, without becoming ill. In 
humans, the reported incubation period for cutaneous 
leishmaniasis can be as short as 1-2 weeks or as long as 
several months when it is caused by New World species, 
and up to three years when Old World species are involved. 
The incubation period for visceral leishmaniasis is 10 days 
to several years; most cases seem to become apparent in 
two to six months. 
Clinical Signs 
Two forms of leishmaniasis, cutaneous and visceral, 
are seen in humans. Some texts also distinguish a 
mucocutaneous form, while others consider it to be a subset 
of cutaneous leishmaniasis. The form of the disease and the 
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usual clinical signs vary with the species of Leishmania. 
Some infections remain asymptomatic. 
Cutaneous leishmaniasis 
Cutaneous leishmaniasis often involves only the skin, 
and may be characterized by one to dozens of lesions. 
Depending on the species of Leishmania, ulcers, smooth 
nodules, flat plaques or hyperkeratotic wart-like lesions 
may be seen. The initial lesions, which occur on skin that 
was exposed to sandflies, are usually papules. Many lesions 
remain localized, but in some cases, the parasites may 
spread via the lymphatics and produce secondary lesions on 
the skin, or occasionally the mucosa, of other parts of the 
body. Regional lymphadenopathy sometimes occurs. 
Cutaneous leishmaniasis is usually painless unless the 
lesions become secondarily infected, and except in the ear, 
the ulcers tend to remain confined to the skin and do not 
affect the subcutaneous tissues. Most skin lesions heal 
spontaneously; however, the speed of healing varies with 
the species of Leishmania. In some cases, it may take 
several months to a year or longer. Some forms leave 
permanent scars. HIV-infected individuals can have 
unusually severe cases, and the disease is more difficult to 
cure. Steroid treatment or other forms of 
immunosuppression can also result in unusually severe 
disease.  
Disseminated leishmaniasis is a rare form of cutaneous 
disease. It is seen especially with L. amazonensis in the 
Western Hemisphere, although other organisms can also be 
involved. It also occurs in the Eastern Hemisphere, often in 
people who have concurrent HIV infections. In diffuse 
cutaneous leishmaniasis, the nodules do not ulcerate but 
they spread widely on the skin. They may cause damage to 
deep tissues, and can persist indefinitely. The diffuse form 
can be incurable in some cases.  
Leishmaniasis recidivans (lupoid leishmaniasis), 
another rare form, is characterized by the development of 
new lesions around the edges of a healed skin lesion. It is 
most often caused by L tropica or L braziliensis, and it does 
not heal without treatment.   
Mucocutaneous leishmaniasis (espundia) usually 
occurs in Latin America, where it is caused by L. 
braziliensis braziliensis and, less often, by L. panamensis/ 
L. guyanensis. Mucocutaneous leishmaniasis tends to occur 
1 to 5 years after cutaneous leishmaniasis caused by these 
organisms has healed, but it can also be seen while skin 
lesions are still present. The initial signs are erythema and 
ulcerations at the nares, followed by destructive 
inflammation that can spread to involve the nasal septum, 
and in some cases, the pharynx or larynx. Frequent 
nosebleeds can be an early sign. The inflammation may 
perforate the nasal septum, cause severe disfigurement of 
the face, or block the pharynx or larynx. In some cases, the 
genitalia may also be involved. Mucocutaneous 
leishmaniasis does not heal spontaneously. 
 
Visceral leishmaniasis 
Visceral leishmaniasis is usually an insidious, chronic 
disease among the inhabitants of endemic areas; however, 
the onset may be acute in travelers from Leishmania-free 
areas. In some cases (especially in Africa), a primary 
granuloma appears on the skin before the systemic signs. 
The most common symptoms of visceral leishmaniasis are a 
prolonged undulant fever, weight loss, decreased appetite, 
signs of anemia, and abdominal distension with 
splenomegaly and hepatomegaly. Thrombocytopenia may 
cause bleeding tendencies, including petechiae or 
hemorrhages on the mucous membranes, and leukopenia 
can result in increased susceptibility to other infections. 
Other symptoms may include coughing, chronic diarrhea, 
darkening of the skin, lymphadenopathy, and in many 
cases, signs of chronic kidney disease. Mild cases with only 
a few symptoms may resolve spontaneously. Unless they 
are treated, most other cases are eventually fatal, often from 
secondary infections and other complications. Fulminant 
disease or atypical cases can also occur, especially in 
patients co-infected with HIV. People with successfully 
treated infections continue to carry the parasite, and the 
disease may recur if they become immunosuppressed. 
Similarly, asymptomatically infected individuals may later 
develop clinical signs.  
Post-kala azar dermal leishmaniasis (PKDL) occurs 
after recovery in some cases of visceral leishmaniasis 
caused by L. donovani. This syndrome is characterized by 
a maculopapular, macular or-nodular rash around the 
mouth, which spreads. In Africa, PKLD is common, 
usually occurs within 6 months of visceral leishmaniasis, 
and typically disappears within a year without treatment. 
In South Asia, this syndrome is relatively rare, occurs 
several years after visceral leishmaniasis has been cured, 
and required prolonged treatment. In India, PKLD is seen 
in 1-3% of successfully treated cases of visceral 
leishmaniasis.  
Communicability 
Leishmaniasis is usually vector-borne, but person-to-
person transmission including vertical (congenital) 
transmission, venereal transmission, and transmission by 
blood transfusion has been reported. Newborns can be 
infected whether or not the mother was symptomatic. 
Humans infected with some species of Leishmania can 
infect sandflies. 
Diagnostic Tests 
Cutaneous leishmaniasis can be diagnosed by direct 
observation of the parasites in skin scrapings, impression 
smears or skin biopsies stained with Giemsa, Leishman’s, 
Wright’s or other stains. Amastigotes are easiest to find in 
recent or active lesions. Polymerase chain reaction assays 
(PCR) are often used for diagnosis in areas where they are 
available. Leishmania spp. can also be cultured. However, 
each species will grow only in certain media, and some 
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species can be difficult to isolate. Novy-MacNeil-Nicole 
(NMN) medium, brain–heart infusion (BHI) medium, 
Evan’s modified Tobie’s medium (EMTM), Grace’s 
medium and Schneider’s Drosophila medium might be 
used initially. Animal inoculation into hamsters may also be 
valuable, especially with contaminated material. 
Diagnosing leishmaniasis by in vitro culture requires 5 to 
30 days, while animal inoculation can take weeks or 
months. The species, subspecies and/or strain can be 
identified by PCR, DNA hybridization, kinetoplast DNA 
restriction endonuclease analysis, isoenzyme analysis, or 
immunological techniques that use monoclonal antibodies. 
A delayed hypersensitivity test, the leishmanin skin test 
(Montenegro skin test), is useful in the diagnosis of 
cutaneous and mucocutaneous leishmaniasis, but it is 
usually negative in the diffuse cutaneous form. Antibodies 
are often slow to develop and of low titer.  
Visceral leishmaniasis can be diagnosed using some 
of the same techniques, including direct observation of the 
parasites. Amastigotes may be found in peripheral blood, 
or more often, in aspirates or biopsy smears from the 
spleen, bone marrow or lymph nodes. PCR, culture or 
animal (hamster) inoculation may be particularly useful 
early, when parasite numbers are low. Serology can also 
be helpful in this form of leishmaniasis. Common 
serological tests used in humans include the 
immunofluorescent antibody test (IFA), direct 
agglutination, enzyme-linked immunosorbent assay 
(ELISA), fast agglutination-screening test (FAST), and a 
rapid immunochromatographic assay (K39 dipstick or strip-
test). Other assays including gel diffusion, complement 
fixation, indirect hemagglutination and countercurrent 
electrophoresis have also been used. Cross-reactions can 
occur in some serological tests with leprosy, Chagas 
disease, malaria and schistosomiasis. The leishmanin skin 
test/ Montenegro skin test is usually negative in cases of 
visceral leishmaniasis, but reactions can be seen once the 
disease is cured. 
Treatment 
Visceral or cutaneous leishmaniasis can usually be 
cured in immunocompetent individuals. Pentavalent 
antimonials can be used where the parasites are sensitive 
to these drugs, but resistance is a major problem in some 
areas. Other drugs such as allupurinol, amphotericin B or 
liposomal amphotericin B, and miltefosine may also be 
used. Most of the drugs used to treat leishmaniasis must 
be given parenterally. Visceral leishmaniasis in AIDS 
patients is often resistant to treatment, and many patients 
relapse.  
Cutaneous leishmaniasis may be treated to speed 
healing, decrease scarring and decrease the risk of mucosal 
disease or relapse. Intralesional, topical or systemic drugs 
may be used, depending on the species of Leishmania and 
the risk of more serious complications. Cryotherapy, 
thermotherapy, or curettage have also been employed in 
some cases. Some cutaneous leishmaniasis lesions that are 
improving may simply be observed, if they are caused by 
relatively benign organisms. Mucosal leishmaniasis is a 
serious condition and it is treated with systemic drugs. 
Prevention 
Preventative measures against sandflies include using 
insect repellents such as DEET, covering exposed skin, and 
staying on higher floors of buildings in the evening or at 
night, as these insects are poor fliers. Fans can also be 
helpful, and insecticidal sprays can be used to kill the 
insects inside houses. Insecticide-treated bed nets decrease 
bites from these insects at night. Untreated bed nets are not 
generally useful: sandflies are very tiny and can pass 
through the mesh of most nets, while bed nets with a very 
narrow mesh may be too hot in warmer climates. 
Insecticide-treated bed sheets, window curtains and slow-
release paint have also been used. Insecticide spraying 
programs have been conducted in some countries. 
Treatment of human patients may be helpful in areas 
where anthroponotic transmission is important. Decreasing 
the incidence of L. infantum in dogs can help protect people 
from this organism. Some studies have shown that 
insecticide-impregnated dog collars protected both dogs and 
children in areas where they were used. Infected dogs have 
been culled in some countries; however, there are doubts 
about the efficacy of these programs, and in some countries, 
such programs would also not be accepted. Many species of 
Leishmania, particularly species that cause cutaneous 
leishmaniasis, have wild animals as their reservoir hosts. 
The only practical way to decrease the incidence of these 
diseases is personal protection with insect repellents and 
other measures. 
Morbidity and Mortality 
Leishmaniasis is a seasonal disease in temperate 
regions. Infections are acquired in the warmer months when 
sandflies are active, and the number of cases fluctuates with 
changes in their populations. Approximately 1–1.5 million 
cases of cutaneous leishmaniasis and 500,000 cases of 
visceral leishmaniasis are estimated to occur worldwide 
each year. However, this is probably an underestimate, as 
many cases are not diagnosed. 
The anthroponotic form of visceral leishmaniasis, 
caused by L. donovani, can affect all ages. Healthy people 
are not particularly susceptible to L. infantum, which causes 
the zoonotic form of this disease. Asymptomatic infections 
with this organism are common, and illness tends to occur 
mainly in young children, or in people who are 
malnourished or immunosuppressed. The case fatality rate 
for untreated disease is 75–95%. The parasites probably 
persist after clinical cure, and symptoms can reappear if the 
individual becomes immunosuppressed. Even with good 
treatment, approximately half of HIV-infected patients 
relapse between 1 month and 3 years later.  
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Cutaneous leishmaniasis is rarely fatal. This form of 
leishmaniasis often heals spontaneously, although some 
lesions may persist for long periods or leave scars. The 
mucocutaneous form caused by L. braziliensi or L. 
panamensis/ L. guyanensis rarely heals spontaneously and 
is disfiguring. Mucocutaneous lesions in the nasopharynx 
can be fatal.  
Infections in Animals 
Species Affected 
Among domesticated animals, dogs are the most 
commonly affected species. Most cases of canine 
leishmaniasis are caused by L. infantum, but other 
organisms can also be found. Clinical cases are also seen 
occasionally in cats, horses, donkeys and mules infected 
with various species of Leishmania. Leishmaniasis is not a 
significant disease in livestock other than equids, but rare, 
isolated cases of cutaneous leishmaniasis have been seen in 
sheep, goats and cattle in Africa, and a Leishmania-infected 
pig was documented in South America. Antibodies to 
Leishmania spp. have also been reported in donkeys, cows, 
and goats in Africa, and pigs in Brazil. Experimentally 
infected sheep or pigs did not become ill. 
Clinical cases have been reported occasionally in wild 
animals or captive wild species including non-human 
primates, bush dogs (Speothos venaticus), hoary zorros 
(Lycalopex vetulus), gray wolves (Canis lupus) and maned 
wolves (Chrysocyon brachyurus). Some experimentally 
infected crab-eating foxes (Cerdocyon thous) and red foxes 
(Vulpes vulpes) also became ill. In Australia, a Leishmania 
spp. has been reported to cause cutaneous lesions in captive 
kangaroos, wallaroos and wallabies (Macropus spp.). 
Each species of Leishmania has one or more primary 
reservoir hosts, although it may also infect and cause 
disease in other species. Canids seem to be the reservoir 
hosts for L. infantum, and dogs are the most important 
species in maintaining this parasite in domestic cycles. It 
also occurs in various wild canids including wolves, foxes, 
jackals, hoary zorros and bush dogs. Infections with L. 
infantum have been reported in a wide variety of 
domesticated and wild animals including cats, equids, wild 
agouti (Dasyprocta agouti), white-eared opossums 
(Didelphis albiventris), Egyptian mongooses (Herpestes 
ichneumon), genets (Geneta geneta), Iberian lynxes (Lynx 
pardinus), rodents, a seal and at least one species of bat 
(Carollia perspicillata). Some of these organisms, 
including cats, might act as secondary reservoirs in some 
areas.  
Known reservoir hosts for the Old World species that 
cause cutaneous leishmaniasis include gerbils, girds and 
other rodents for L. major, and members of the Hyracoideas 
(hyraxes) for L. aethiopica. The New World species that 
cause cutaneous leishmaniasis are often maintained among 
animals that live in forests. The primary reservoir host(s) 
for L. braziliensis are not known; however, a variety of 
species including carnivores, rodents and perissodactyls, as 
well as dogs, cats and equids, are reported to be infected 
with this species. It is possible that different reservoir hosts  
are important in different areas. Important reservoir hosts 
for other New World species include sloths for L. 
guyanensis/ L. panamensis, armadillos for L. naiffi, and 
rodents for L. mexicana, L. amazonensis and L. lainsoni. 
Marsupials including members of the genera Didelphis, 
Philander, Marmosa, Caluromys and Metachirus, and the 
crab-eating fox can also be infected with L. amazonensis, 
although rodents are thought to be the primary reservoirs. 
Dogs are the only known reservoir hosts for L. peruviana, 
which causes human cutaneous leishmaniasis in the 
Peruvian Andes. Arboreal mammals are suspected to be the 
reservoir hosts for L. shawi, which has been reported in 
monkeys (the black bearded saki, Chiropotes satanas), 
sloths (Choloepus didactylus and Bradypus tridactylus) and 
coatis (Nasua nasua). The reservoir hosts for L. 
venezuelensis, which has been reported in humans and cats, 
are unknown. Humans are the reservoir hosts for two Old 
World species: L. tropica, which causes cutaneous 
leishmaniasis, and L. donovani, which causes visceral 
leishmaniasis. 
Incubation Period 
Animals are often infected asymptomatically with 
Leishmania spp. The reported incubation period for L. 
infantum in dogs varies from three months to seven years. 
In some dogs, severe clinical signs occur soon after animal 
becomes infected. Other dogs remain asymptomatically 
infected, in some cases for a lifetime. These animals can 
become ill at any time, particularly when they become 
immunosuppressed.  
Clinical Signs 
Dogs 
Both visceral and cutaneous manifestations may be 
found simultaneously in dogs; unlike humans, separate 
cutaneous and visceral syndromes are not seen. The clinical 
signs are variable and can mimic other infections. 
Asymptomatic infections can also occur.  
In symptomatic cases, common visceral signs include 
lethargy, weight loss, a decreased appetite, anemia, 
splenomegaly and local or generalized lymphadenopathy. 
Fever can be intermittent, and is absent in many cases. 
Bleeding disorders including epistaxis, hematuria and 
melena can also be seen. In some cases, profuse epistaxis is 
the only presenting sign. Chronic renal disease is common 
in dogs infected with L. infantum; it may be the only 
syndrome, and it is often the cause of death. Some animals 
may also have ocular, skin or mucosal lesions, sneezing, 
chronic diarrhea, vomiting, chronic relapsing colitis, 
chronic hepatitis, osteolytic and osteoproliferative bone 
lesions, meningitis, autoimmune disorders, and 
cardiovascular signs from pericarditis, thromboembolism, 
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vasculitis and serum hyperviscosity. Erosive or nonerosive 
polyarthritis may be seen, and chronic polymyositis can 
cause progressive muscle atrophy. In symptomatic cases, 
the disease is usually slowly progressive.  
Skin lesions are common in dogs with visceral 
disease, but they can also occur separately. The most 
common cutaneous syndrome is a non-pruritic exfoliative 
dermatitis, found especially around the eyes and on the 
face, ears or feet. There may be areas of alopecia, 
especially around the eyes, and silvery white scales in the 
areas of alopecia. In some cases, the lesions may be 
generalized. Cutaneous disease characterized by nodules, 
ulcers or scabs can also occur in dogs. Atypical skin 
lesions including pustular rashes, panniculitis, 
depigmentation, erythema multiforme, digital and nasal 
hyperkeratosis, and cases that resemble alopecia areata or 
pemphigus foliaceus have also been reported. Secondary 
bacterial infections are common. In some dogs with 
cutaneous lesions, the nails may be abnormally long and 
brittle. Marked wasting of the temporal muscles may also 
be seen.  
Ocular lesions may be seen independently from 
systemic signs, and can occur before or after treatment. The 
most common ocular signs are blepharitis, conjunctivitis, 
keratitis and anterior uveitis. Some animals have multiple 
granulomas at the eyelid margins, nictitating membrane 
margins, conjunctival limbus, cornea, or anterior chamber. 
Sequelae may include glaucoma, keratoconjunctivitis sicca, 
corneal pigmentation, iris atrophy, cataracts, retinal 
detachment, panophthalmitis or phtisis bulbi. 
Cats 
Clinical cases are uncommon in cats. Most reported 
cases have been characterized by cutaneous signs without 
visceral lesions. Localized nodules, papules and chronic 
crusted or ulcerated lesions  are most often found on the 
nose, ears (pinnae), eyelids or lips, but they can also occur 
on other sites such as the paws. The nasal mucosa may be 
involved, and the regional lymph nodes may be enlarged. 
Generalized dermatitis, alopecia and scales can also be 
seen. Both fatal cases and spontaneous cures have been 
reported. In one otherwise healthy cat infected with L. 
mexicana, skin lesions recurred two years after surgical 
treatment, and were refractory to therapy. 
Visceral lesions and signs are rare. Systemic cases in 
cats have involved the liver, spleen, lymph nodes and 
kidney. Fever, jaundice, vomiting, lymphadenopathy, oral 
and ocular lesions, anemia and leukopenia have been 
reported. Severe pancytopenia was the main syndrome in 
one infected cat presented for depression and loss of 
appetite. Some sick cats were co-infected with 
immunosuppressive viruses such as feline 
immunodeficiency virus or feline leukemia virus, but others 
were not.  
 
Equidae 
Horses, mules and donkeys may develop skin lesions, 
particularly on the head, ears, neck, legs and scrotum. The 
most common lesions are solitary or multiple papules or 
nodules, which are often ulcerated, Disseminated skin 
disease has been reported, but visceral leishmaniasis has not 
been documented in equids. Some lesions regress 
spontaneously. 
Other domesticated animals 
Skin lesions were the only clinical signs reported in a 
sheep, goat and calf in Africa. The goat also had enlarged 
lymph nodes. Experimentally infected sheep had no clinical 
signs except an elevated temperature. Experimentally 
infected pigs remained asymptomatic. 
Captive wild species and wild animals 
Infections seem to be inapparent in many infected wild 
animals. In rodents, the L. mexicana complex may cause 
swellings with hair loss or ulcers, particularly at the base of 
the tail but also on the ears or toes. The few reported cases 
in captive or wild canids have resembled canine 
leishmaniasis. In a captive bush dog infected with L. 
infantum, the clinical signs included progressive weight 
loss, vomiting, diarrhea, anemia and signs of kidney disease 
including polyuria and polydipsia. This animal later 
developed ascites and cervical edema, and eventually died. 
A hoary zorro infected with the same organism developed 
an enlarged cervical lymph node, followed by ulcerated 
skin lesions, anemia, weakness, prostration and weight loss. 
Multiple chronic ulcerative skin lesions were seen in a 
captive maned wolf. Fatal L. infantum infection was also 
reported in a wild gray wolf in Croatia. The animal was 
found dead, with generalized alopecia, decreased elasticity 
of the skin, skin ulcers, white scaling, and disseminated 
crusted erosions. Generalized lymphadenopathy, 
hepatosplenomegaly, cardiac dilation, hydropericardium 
and hydrothorax, as well as pulmonary edema, 
consolidation and disseminated focal pulmonary 
hemorrhages were found at necropsy.  
Captive Australian marsupials developed skin lesions 
consisting of focal to coalescing areas of thickened skin, or 
raised crusted or ulcerative pale nodules. Some nodules 
were found around the eyes or on the cloaca. 
Communicability 
Transplacental transmission has been documented in 
dogs and rodents, and venereal transmission has been seen 
in experimentally infected dogs. Leishmania spp. can also 
be acquired in blood transfusions. Case histories suggest 
that, in rare cases, these parasites might have been 
transmitted between dogs during fights, or acquired during 
other forms of close contact, possibly when a dog licked 
another dog’s wounds or ingested blood during 
hemorrhages. In general, horizontal transmission between 
dogs seems to be rare. The risk of transmission to humans is 
unknown. 
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Dogs and cats can transmit Leishmania spp. to 
sandflies; however, experimentally infected pigs could not. 
Some animals may act as bridges that bring parasites found 
in sylvatic cycles closer to humans. 
Post-Mortem Lesions      Click to view images 
The gross lesions are highly variable and may be 
minimal. In canids, the lesions may include cachexia, signs 
of anemia, generalized lymphadenopathy, 
hepatosplenomegaly, areas of alopecia with desquamation 
on the head and trunk, and cutaneous ulcers or nodules. 
Ulcers and petechiae are occasionally seen on the mucous 
membranes, and in some cases, hemorrhages may be 
evident in internal organs. Small, light colored nodular foci 
(granulomas) may be found in a variety of organs, including 
the kidney, liver, and pancreas. In experimentally infected 
dogs, fetuses had no lesions despite the presence of 
parasites in their tissues. 
In a cat with severe pancytopenia caused by 
leishmaniasis, the only gross lesions were poor condition, 
mild hepatomegaly and pulmonary edema.  
Diagnostic Tests 
In animals, leishmaniasis may be diagnosed by direct 
observation of the parasites using Giemsa, Wright’s, 
Leishman’s or other stains. Leishmania amastigotes are 
round to oval parasites, with a round basophilic nucleus and 
a small rod-like kinetoplast. They are usually found in 
macrophages or freed from ruptured cells. In dogs, 
amastigotes can sometimes be found in lymph node, spleen, 
or bone marrow aspirates, or in skin scrapings from lesions. 
In sick animals, they may also be found in other affected 
tissues, including ocular granulomas. However, parasites 
are sometimes undetectable even in clinical cases, and they 
are often absent in asymptomatically infected animals. 
Histopathology with immunohistochemistry can increase 
the likelihood of detecting the organism when few parasites 
are present.  
PCR is particularly sensitive, and can be used to detect 
Leishmania spp. in blood, skin biopsies, lymph nodes, bone 
marrow and conjunctival swabs. Leishmania species can 
also be cultured in a variety of media. However, there is no 
single universal culture medium for this organism; each 
species will grow only in certain media and some can be 
difficult to isolate. Media that can be used for Leishmania 
spp. include Novy-MacNeil-Nicole NMN) medium, brain–
heart infusion (BHI) medium, Evan’s modified Tobie’s 
medium (EMTM), Grace’s medium or Schneider’s 
Drosophila medium. Animal inoculation into hamsters may 
also be valuable, especially with contaminated material. 
Diagnosing leishmaniasis by in vitro culture requires 5 to 
30 days, while animal inoculation can take weeks or 
months. The species, subspecies, and/or strain is identified 
by specialized techniques including isoenzyme analysis, 
PCR, DNA hybridization, kinetoplast DNA restriction 
endonuclease analysis, or immunological methods that use 
monoclonal antibodies.  
The most commonly used serological tests are the 
indirect fluorescent antibody test and ELISAs. A rapid 
immunochromatographic assay (rK39 dipstick or strip-test) 
is also available. Other serological tests including direct 
agglutination, counterimmunoelectrophoresis, complement 
fixation, indirect hemagglutination, latex agglutination, 
immunodiffusion or immunoblotting may also be available. 
Most, but not all, symptomatically infected dogs are 
seropositive. However, only a percentage of 
asymptomatically infected dogs have detectable antibodies, 
and these animals may or may not become ill. Antibodies 
are not always found in animals that only have localized 
skin lesions; in cats, titers may not be detected until the 
lesions are resolving. Serological studies also suggest that 
Leishmania titers may be lower in cats than dogs. Cross-
reactions can occur with other parasites, particularly 
Trypanosoma cruzi; these reactions are more common in 
tests that use crude antigen preparations. The delayed 
hypersensitivity test, which is used in humans, is not useful 
for dogs. 
Treatment 
Treatment can produce clinical improvement, although 
it may not eliminate the parasite. Pentavalent antimonials 
are often used for treatment where they are available. In the 
U.S., these drugs are provided through the Centers for 
Disease Control and Prevention (CDC). Other drugs used in 
humans, such allopurinol, amphotericin B, or second line 
drugs may also be employed, either alone or in 
combination. Allopurinol has been used as a maintenance 
drug to prevent relapses. The prognosis is poorer in dogs 
that are severely ill and animals with kidney disease. In 
areas where leishmaniasis is not endemic, euthanasia may 
be considered to decrease the risk of transmission to 
humans, particularly if a competent sandfly vector is 
present. 
Prevention 
Insecticide-impregnated collars or topical insecticides 
are used in dogs to decrease bites from sandflies. Keeping 
susceptible animals, including dogs, cats and horses, 
indoors between dusk and dawn can be helpful during the 
warmer months when sandflies are active. Kennels and 
homes may be sprayed with insecticides, and insecticide-
treated door and kennel nets and curtains may be helpful in 
keeping sandflies out. These insects are tiny and can get 
through untreated mesh unless it is extremely fine. 
However, they are poor fliers and are deterred by wind; 
fans can be helpful. Habitat modifications around the home 
can also be considered.  
Because congenital infections can occur, it may not be 
advisable to breed from infected dogs. A vaccine has 
recently been licensed for dogs in Brazil.  
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Morbidity and Mortality 
Leishmaniasis is a seasonal disease in temperate 
regions. Infections are acquired in the warmer months when 
sand flies are active, and the number of cases fluctuates 
with changes in the number of vectors. When the densities 
of both dogs and sandflies are high, L. infantum can be 
transmitted widely and rapidly among dogs. In endemic 
areas, up to 63-80% of the canine population can be 
infected with this organism. However, far fewer dogs will 
develop clinical signs. Although some dogs become 
severely ill soon after they are infected, up to 90% or more 
of L. infantum-infected dogs may be asymptomatic. Some 
of these dogs will develop clinical signs after months to 
years, often when they become immunosuppressed. Others 
may never become ill. Asymptomatic L. infantum infections 
also seem to be common in other canids. Only 6 of 75 
experimentally infected crab-eating foxes, and 2 of 30 
infected red foxes developed clinical signs. Similarly to 
dogs, the prevalence of this organism may be high in wild 
canids.  
Sporadic cases of leishmaniasis, usually of the 
cutaneous form, occur in cats, horses, donkeys and rarely 
other species. One experimental study suggested that cats 
have some natural resistance to Leishmania. Because 
clinical cases are uncommonly reported in this species, 
Leishmania infections were also assumed to be rare. 
However, recent studies suggest that significant numbers 
of cats might be subclinically infected in some areas. 
Serological surveys in Europe have found antibodies to 
this organism in 0.6-60% of cats. In one study from Spain, 
60% of the cats tested were seropositive and L. infantum 
DNA was found in 26%, with some animals infected for 
months. In another Spanish study, 4% of the cats were 
seropositive and one cat (0.43%) was positive by PCR. In 
the Middle East, a study found a seroprevalence of 
approximately 7% among cats in Israel, and parasites were 
isolated from 4 of 40 cats (10%) in Iran. Amastigotes were 
also found in spleen smears from 16 of 78 cats (20%) in 
Jordan. In Brazil, a study in 1938 and one in 1996 found 
very few infected cats, but a 2008 study that used PCR 
reported that 2 of 8 asymptomatic cats were infected.  
Internet Resources 
Centers for Disease Control and Prevention (CDC) 
http://www.cdc.gov/ncidod/dpd/parasites/leishmania/d
efault.htm 
Medical Microbiology 
http://www.ncbi.nlm.nih.gov/books/NBK7627/ 
Public Health Agency of Canada. Material Safety  
Data Sheets 
http://www.phac-aspc.gc.ca/msds-ftss/index.html 
The Merck Manual 
http://www.merck.com/pubs/mmanual/ 
The Merck Veterinary Manual 
http://www.merckvetmanual.com/mvm/index.jsp 
World Health Organization 
http://www.who.int/leishmaniasis/en/ 
World Organization for Animal Health (OIE) 
http://www.oie.int 
OIE Manual of Diagnostic Tests and Vaccines for  
Terrestrial Animals 
http://www.oie.int/international-standard-
setting/terrestrial-manual/access-online/ 
OIE Terrestrial Animal Health Code 
http://www.oie.int/international-standard-
setting/terrestrial-code/access-online/ 
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